Li-Hong Yeh InspectorProfile


This InspectorProfile is a report of relevant audit-related information on Li-Hong Yeh, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Human Drugs.

Product Description

This InspectorProfile report is updated through and lists Li-Hong Yeh's 11 inspections in 4 countries: Canada, India, South Africa, and Switzerland.

FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Li-Hong Yeh's inspection information so that you can mitigate investigator-related risks.

Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Li-Hong Yeh.

Example Report

Li-Hong Yeh FDA InspectorProfile Overview Example
Li-Hong Yeh FDA InspectorProfile Metrics Example
Li-Hong Yeh FDA InspectorProfile Citations Example
Li-Hong Yeh FDA InspectorProfile Inspections List
Add To Cart

Product details

  • Li-Hong Yeh's metrics:
    • 483 issue rate, total inspections, total 483s
    • Most common citations (based on CFR), CFR description, and citation frequency
    • Total inspections, total 483s
    • Longest / shortest inspection in duration - all time, last year
    • Total warning letters
  • Inspection details for each inspection (since 2000) Li-Hong Yeh has conducted including:

Note: The EIR and 483 documents are sold separately.

Add To Cart